Showing 3291-3300 of 4063 results for "".
- Zeiss Surpasses 8 Million Eyes Treated with SMILE Worldwidehttps://modernod.com/news/zeiss-surpasses-8-million-eyes-treated-with-smile-worldwide/2481789/Zeiss announced that more than 8 million eyes have been treated with Small Incision Lenticule Extraction (SMILE) globally to date. The FDA approved the VisuMax Femtosecond Laser for the SMILE procedure in 2016. “Zeiss SMILE is a game-changer for lase
- ESCRS Launches New Clinical Research Award Call Focusing on Presbyopic IOLs in Post-Refractive Cataract Patientshttps://modernod.com/news/escrs-launches-new-clinical-research-award-call-focusing-on-presbyopic-iols-in-post-refractive-cataract-patients/2481768/The European Society of Cataract & Refractive Surgeons (ESCRS) announced the opening of a call for applications for the 2023 Clinical Research Award. The ESCRS Clinical Research Awards (CRA) is an initiative by the ESCRS to support and encourage independent clinical research in the
- Skyline Therapeutics’ Gene Therapy Candidate for Wet AMD Receives IND Clearancehttps://modernod.com/news/skyline-therapeutics-gene-therapy-candidate-for-namd-receives-ind-clearance/2481758/Skyline Therapeutics announced that the FDA has cleared the company’s investigational new drug (IND) application for a phase 1/2a clinical trial of SKG0106, a one-time intravitreally delivered adeno-associated virus (AAV) gene therapy for the treatment of wet age-related macular degene
- RestoringVision Appoints of Three Directors to its Leadership Teamhttps://modernod.com/news/restoringvision-appoints-of-three-directors-to-its-leadership-team/2481739/Nonprofit RestoringVision announced the appointment of three directors to its leadership team to strengthen its impact in solving the global vision crisis. This follows a year of growth, in which RestoringVision expanded its reach by 48 percent in 2022. In 2023, the organization aims to reac
- Genentech Presents Post-Hoc Clinical and Real-World Data for Vabysmo at ASRShttps://modernod.com/news/genentech-presents-post-hoc-clinical-and-real-world-data-for-vabysmo-at-asrs/2481737/Genentech announced that data from its ophthalmology portfolio will be highlighted in 25 abstracts at the 2023 American Society of Retina Specialists (ASRS) annual meeting, which will be held from July 28-August 1 in Seattle. The data advance the clinical and real-world evidence supporting t
- Visiox Pharma Licenses Glaucoma Drug Omlonti from Santenhttps://modernod.com/news/visiox-pharma-licenses-glaucoma-drug-omlonti-from-santen/2481736/Visiox Pharma announced it has entered into a definitive agreement with Santen Pharmaceutical to license glaucoma drug Omlonti (omidenepag isopropyl ophthalmic solution 0.002%). Specific financial terms of the deal were not disclosed. Omlonti was approved by th
- Lars Ederleh Named New CSO at Schwind Eye-Tech-Solutionshttps://modernod.com/news/lars-ederleh-named-new-cso-at-schwind-eye-tech-solutions/2481731/Schwind eye-tech-solutions has named Lars Ederleh as Chief Sales Officer (CSO), effective this month. Bringing more than 20 years of international experience in laser technology, Mr. Ederleh will be in charge of the company’s sales and marketing operations.
- National Eye Institute Names Kapil Bharti New Scientific Directorhttps://modernod.com/news/kapil-bharti-is-neis-new-scientific-director/2481726/The National Eye Institute (NEI) has named Kapil Bharti was Scientific Director, effective May 2023. “Dr. Bharti is a world-class translational vision scientist, a thoughtful planner who understands interdisciplinar
- Kiora Pharmaceuticals Receives $1.2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Diseasehttps://modernod.com/news/kiora-pharmaceuticals-receives-12-million-in-research-tax-credits-to-advance-the-treatment-of-ophthalmic-disease/2481713/Kiora Pharmaceuticals announced its wholly owned subsidiaries have received, in aggregate, $1.2 million related to research tax incentives from the Austrian and Australian governments for research expenditures performed in 2021 and 2022. The funds were received as part of government incentiv
- Heidelberg Engineering Names Hartmut Becker Head of Global Saleshttps://modernod.com/news/heidelberg-engineering-names-hartmut-becker-head-of-global-sales/2481710/Heidelberg Engineering has introduced Hartmut Becker as new Head of Global Sales, effective April 2023. In his new role, he will be leading the company’s sales and distribution activities across the group, and is responsible for supporting Heidelberg Engineering’s direct sub